Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump

Clin Res Cardiol. 2013 Feb;102(2):155-7. doi: 10.1007/s00392-012-0494-5. Epub 2012 Jul 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Blood Coagulation Tests
  • Bromocriptine / adverse effects*
  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / etiology
  • Cardiomyopathies / physiopathology
  • Cardiomyopathies / therapy*
  • Dopamine Agonists / adverse effects*
  • Echocardiography, Doppler, Color
  • Echocardiography, Transesophageal
  • Female
  • Heart-Assist Devices / adverse effects*
  • Humans
  • Peripartum Period
  • Pregnancy
  • Puerperal Disorders / diagnosis
  • Puerperal Disorders / etiology
  • Puerperal Disorders / physiopathology
  • Puerperal Disorders / therapy*
  • Thrombosis / diagnosis
  • Thrombosis / drug therapy
  • Thrombosis / etiology*
  • Treatment Outcome
  • Ventricular Function, Left

Substances

  • Anticoagulants
  • Dopamine Agonists
  • Bromocriptine